Corporate Development Manager

Iterative Health is a healthcare technology and services company powering the acceleration of clinical research to transform patient outcomes.

We built a leading performance-driven network of 100+ sites across the US, Europe, India, and Australia, conducting research directly in the communities where care is delivered across gastrointestinal, hepatology, obesity, and cardiology. By combining deep clinical trial expertise with cutting-edge AI, we connect sponsors' scientific ambitions with high-performing research teams that expedite and expand access to novel therapeutics for patients in need. Today, Iterative Health is headquartered in Cambridge, Massachusetts, and New York City with 250+ employees world-wide.

Corporate Development is a critical driver of Iterative Health’s growth strategy. As we expand our site network and increase transaction activity, the Corporate Development team plays a key role in identifying, evaluating, and executing opportunities that accelerate our growth.

As a Corporate Development Manager, you will support the full M&A lifecycle—from sourcing and evaluating potential acquisitions through due diligence, transaction execution, and integration. Reporting to the VP, Corporate Development, you will work closely with the Executive Team and cross-functional leaders across Iterative Health, gaining significant exposure to high-impact, company-shaping decisions.

This is an opportunity to join a growing function at an important stage of IH’s evolution and directly contribute to the expansion of our research site network.

Where You’ll Drive Impact 

Identify, research, and prioritize potential acquisition targets and strategic management contract opportunities aligned with IH’s growth strategy.

Engage directly with acquisition candidates and help position Iterative Health as their preferred partner or buyer.

Coordinate and structure due diligence materials across financial, legal, tax, operational, and other workstreams for internal and external stakeholders, including management, the Board, investors, and lenders.

Build and refine financial analyses, presentations, and other materials used to evaluate opportunities and communicate recommendations to acquisition targets and internal stakeholders.

Partner with the VP, Corporate Development and cross-functional teams to advance transactions from initial evaluation through closing.

Support the seamless integration of acquired companies into Iterative Health, helping coordinate activities across functions and ensuring key priorities remain on track.

Collaborate with leaders across Finance, Legal, Operations, Clinical Research, People, and other functions to ensure alignment throughout the M&A process.

Translate complex financial and operational information into clear insights that support investment and growth decisions.

Perform other tasks as assigned

What You Bring to the Team 

3-5 years of experience in Corporate Development, Investment Banking, Private Equity, or a related analytical or transaction-focused environment.

Experience contributing to M&A processes, including sourcing, financial analysis, due diligence, transaction execution, or integration.

Strong analytical skills and demonstrated ability to build financial models and analyses in Excel.

Strong PowerPoint and presentation development skills, with the ability to communicate complex information clearly and effectively.

Highly organized and structured, with exceptional attention to detail and the ability to manage multiple workstreams simultaneously.

Strong written and verbal communication skills and comfort working with senior leaders and external stakeholders.

Ability to operate with a high degree of ownership in a fast-paced, dynamic environment.

Sound business judgment, curiosity, and a willingness to dive into complex problems and develop practical solutions.

Preferred Qualifications

Experience supporting a high volume o …